Dr. Balentine received his undergraduate degree from McDaniel College in Westminster, Maryland. He attended medical school at the Philadelphia College of Osteopathic Medicine graduating in1983. He completed his internship at St. Joseph's Hospital in Philadelphia and his Emergency Medicine residency at Lincoln Medical and Mental Health Center in the Bronx, where he served as chief resident.
Author: Gayle M. Galletta, MD,
FACEP, Clinical Associate Professor, Department of Emergency Medicine, University of Massachusetts.
Editor: Jerry R. Balentine, DO,
Previous contributing coauthor and editors:
Hasnain M. Khandwala, MD, FRCPC, Assistant Professor, Department of Medicine, Division of Endocrinology, University of Saskatchewan, Canada.
Editors: Arthur B. Chausmer, MD, PhD, FACP, FACE, FACN, CNS, Affiliate Research Professor, Bioinformatics and Computational Biology Program, School of Computational Sciences; Principal, C/A Informatics, LLC; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; George T Griffing, MD, Director, Division of General Internal Medicine, Professor, Department of Internal Medicine, St Louis University.
Allison, D.B., et al. "Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP)." Obesity 20.2 Feb. 2012: 330-342.
Douketis, J.D., C. Macie, L. Thabane, and D.F. Williamson. "Systematic Review of Long-Term Weight Loss Studies in Obese Adults: Clinical Significance and Applicability to Clinical Practice."
Int J Obesity (2005): 1153-1167.
Ebbeling, C.B., and D.S. Ludwig. "Tracking Pediatric Obesity, an Index of Uncertainty?" JAMA (2008): 2442-2443.
Fidler, M.C., et al. "A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial." J Clin Endocrinol Metab 96.10 Oct. 2011: 3067-3077.
Flegal, K.M., M.D. Carroll, C.L. Ogden, and L.R. Curtin. "Prevalence and Trends in Obesity Among U.S. Adults, 1999-2008." JAMA 303.3 (2010): 235–241.
Gadde, K.M., et al. "Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomized, placebo-controlled, phase 3 trial."
Lancet 377.9774 Apr. 16, 2011: 1341-1352.
Kernan, W.N., C.M. Viscoli, L.M. Brass, et al. "Phenylpropanolamine and the Risk of Hemorrhagic Stroke." N Engl J Med 343 (2000): 1826.
Klein, S., et al. "Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease." N Engl J Med 250.25 (2004): 2549-2557.
Klein, S., et al. "Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease: A Statement for Professionals From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation." Circulation 110.18 (2004): 2952-2967.
Li, Z., et al. "Meta-analysis: Pharmacologic Treatment on Obesity." Ann Intern Med 142.7 (2005): 532-546.
O'Brien, P.E., et al. "Treatment of Mild to Moderate Obesity With Laparoscopic Adjustable Gastric Banding or an Intensive Medical Program: A Randomized Trial." Ann Int Med 144.9 (2006): 625-633.
Ogden, C.L., M.D. Carroll, and K.M. Flegal. "High Body Mass Index for Age Among US Children and Adolescents, 2003-2006." JAMA 299.20 (2008): 2401-2405.
Padwal, R., S.K. Li, and D.C. Lau. "Long-term Pharmacotherapy for Obesity and Overweight." Cochrane Database Syst Rev (2004).
Poirier, P., et al. "Obesity and Cardiovascular Disease: Pathophysiology, Evaluation and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical activity, and Metabolism." Circulation 113.6 (2006): 898-918.
Sjostrom, L., et al. "Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years After Bariatric Surgery." N Engl J Med (2004): 2683-2693.
Whitmer, R.A., et al. "Central Obesity and Increased Risk of Dementia More Than Three Decades Later." Neurology (2008).